EUVIMEDEUVIMED entdecken
LeitlinieMetaanalyseÜbersichtsarbeitOpen Access

International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma

Valentina Pinzi iD, Rupesh Kotecha iD, Arjun Sahgal, Alessandra Gorgulho, Mary Jane Lim-Fat, Marc Levivier, Lijun Ma, Ian Paddick iD, Jean Regis, Jason P Sheehan, John H Suh, Shoji Yomo und 1 weitere

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noaf247 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Valentina Pinzi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico C Besta, Milan, Italy (V.P., L.F.). Hauptthemen laut MEDLINE: Radiosurgery, Glioma, Brain Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recurrence invariably occurs in patients with high-grade glioma (HGG) despite maximal definitive therapy. Currently, there is no standard-of-care salvage treatment approach and re-irradiation is considered an option for select patients. Various radiotherapy fractionation schedules have been investigated, including the use of stereotactic radiosurgery (SRS). The aim of this study was to provide clinical practice recommendations on behalf of the International Stereotactic Radiosurgery Society (ISRS) specific to salvage SRS for recurrent-HGG. We define SRS as focal radiation in a single fraction and hypofractionated radiosurgery (HFSRS) as focal radiation delivered over 2-5 fractions.

Methods

A literature review and meta-analysis were performed according to PRISMA guidelines. Recommendations were formulated according to DELPHI methodology.

Results

Sixty-two studies met the eligibility criteria for analyses, resulting in 2640 recurrent HGG patients. Stereotactic radiosurgery to a median total dose of 16 Gy was performed in 75% of patients, and HFSRS to the remaining 25% with a median total dose and number of fractions of 25 Gy and 5 fractions, respectively. The median overall survival from re-irradiation was 10.2 months. The pooled neurological toxicity rates were lower with HFSRS compared to SRS (4% vs. 7%, P = 0.001). A cumulative EQD2 greater than 120-130 Gy was significantly associated with a greater risk of radiation necrosis (P = 0.003).

Conclusions

Focal re-irradiation with 16 Gy in single fraction or 24-25 Gy in 3-5 fractions, is safe and appears to be effective for recurrent-HGG. We also present clinical practice recommendations on behalf of the ISRS. Given the limited prospective data, no definitive conclusions can be drawn.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryGliomaBrain NeoplasmsNeoplasm Recurrence, LocalPractice Guidelines as TopicHumansSalvage TherapyNeoplasm GradingSocieties, Medical

Stichwörter der Autor:innen

gliomaradiosurgeryre-irradiationrecurrencestereotactic radiotherapy

Autor:innen und Institutionen

  • Department of Neurosurgery, Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico C Besta, Milan, Italy (V.P., L.F.).
  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida (R.K.).
  • Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (A.S.).
  • Department of Neurosurgery, State University of São Paulo, NeuroSapiens Group, São Paulo, Brazil (A.G.).
  • D'Or Institute for Research and Education, São Paulo, Brazil (A.G.).
  • Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (M.J.L.-F.).

ORCID-Profile: Valentina Pinzi, Rupesh Kotecha, Ian Paddick

Zitieren

APA

Pinzi, V., Kotecha, R., Sahgal, A., Gorgulho, A., Lim-Fat, M. J., Levivier, M., Ma, L., Paddick, I., Regis, J., Sheehan, J. P., Suh, J. H., Yomo, S., & Fariselli, L. (2026). International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf247

Vancouver

Pinzi V, Kotecha R, Sahgal A, Gorgulho A, Lim-Fat MJ, Levivier M, et al. International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma. Neuro-Oncology. 2026. doi:10.1093/neuonc/noaf247

BibTeX
@article{Pinzi2026,
  author = {Pinzi, Valentina and Kotecha, Rupesh and Sahgal, Arjun and Gorgulho, Alessandra and Lim-Fat, Mary Jane and Levivier, Marc and Ma, Lijun and Paddick, Ian and Regis, Jean and Sheehan, Jason P and Suh, John H and Yomo, Shoji and Fariselli, Laura},
  title = {International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noaf247}
}
Kostenlos starten →